James Ihle

1.4k total citations
18 papers, 1.0k citations indexed

About

James Ihle is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, James Ihle has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Hematology and 5 papers in Immunology. Recurrent topics in James Ihle's work include Cytokine Signaling Pathways and Interactions (7 papers), Acute Myeloid Leukemia Research (5 papers) and Virus-based gene therapy research (4 papers). James Ihle is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Acute Myeloid Leukemia Research (5 papers) and Virus-based gene therapy research (4 papers). James Ihle collaborates with scholars based in United States, Canada and Austria. James Ihle's co-authors include T. Kent Teague, John W. Kappler, Philippa Marrack, Anthony T. Vella, Evan Parganas, Harinder Singh, Karen L. Reddy, Eric Bertolino, Kay L. Medina and John N. Fain and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

James Ihle

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Ihle United States 14 544 347 310 185 146 18 1.0k
Ikuya Sakai Japan 17 299 0.5× 419 1.2× 453 1.5× 151 0.8× 75 0.5× 50 1.0k
Kazuhiro Hayashida Japan 17 725 1.3× 367 1.1× 336 1.1× 144 0.8× 101 0.7× 44 1.4k
H E Broxmeyer United States 14 392 0.7× 278 0.8× 346 1.1× 174 0.9× 123 0.8× 15 817
Patrizia Mella Italy 18 553 1.0× 238 0.7× 281 0.9× 199 1.1× 258 1.8× 29 1.2k
Hervé Brailly France 20 824 1.5× 299 0.9× 582 1.9× 185 1.0× 62 0.4× 33 1.4k
Janet M.D. Plate United States 18 807 1.5× 402 1.2× 557 1.8× 60 0.3× 97 0.7× 48 1.4k
Emiel Van Roost Belgium 11 855 1.6× 234 0.7× 383 1.2× 77 0.4× 87 0.6× 14 1.3k
Deborah L. Hodge United States 21 712 1.3× 321 0.9× 226 0.7× 95 0.5× 55 0.4× 31 1.2k
R Weber-Nordt Germany 11 930 1.7× 313 0.9× 798 2.6× 214 1.2× 62 0.4× 15 1.5k
Ilana Yron Israel 20 789 1.5× 335 1.0× 432 1.4× 73 0.4× 86 0.6× 42 1.3k

Countries citing papers authored by James Ihle

Since Specialization
Citations

This map shows the geographic impact of James Ihle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Ihle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Ihle more than expected).

Fields of papers citing papers by James Ihle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Ihle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Ihle. The network helps show where James Ihle may publish in the future.

Co-authorship network of co-authors of James Ihle

This figure shows the co-authorship network connecting the top 25 collaborators of James Ihle. A scholar is included among the top collaborators of James Ihle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Ihle. James Ihle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ming‐Lum, Andrew, Christopher J. Ong, Michael Cox, et al.. (2005). Divergent Mechanisms Utilized by SOCS3 to Mediate Interleukin-10 Inhibition of Tumor Necrosis Factor α and Nitric Oxide Production by Macrophages. Journal of Biological Chemistry. 281(10). 6316–6324. 82 indexed citations
2.
Bertolino, Eric, Karen L. Reddy, Kay L. Medina, et al.. (2005). Regulation of interleukin 7–dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nature Immunology. 6(8). 836–843. 111 indexed citations
3.
Ihle, James. (2001). Pathways in Cytokine Regulation of Hematopoiesis. Annals of the New York Academy of Sciences. 938(1). 129–130. 3 indexed citations
4.
Fain, John N., James Ihle, & Suleiman W. Bahouth. (1999). Stimulation of Lipolysis but Not of Leptin Release by Growth Hormone Is Abolished in Adipose Tissue from Stat5a and b Knockout Mice. Biochemical and Biophysical Research Communications. 263(1). 201–205. 55 indexed citations
5.
Vella, Anthony T., T. Kent Teague, James Ihle, John W. Kappler, & Philippa Marrack. (1997). Interleukin 4 (IL-4) or IL-7 Prevents the Death of Resting T Cells: Stat6 Is Probably Not Required for the Effect of IL-4. The Journal of Experimental Medicine. 186(2). 325–330. 238 indexed citations
6.
Ihle, James. (1995). TheJanusprotein tyrosine kinases in hematopoietic cytokine signaling. Seminars in Immunology. 7(4). 247–254. 52 indexed citations
7.
8.
Rothman, Paul B., Mohd Azam, David T. Levy, et al.. (1994). Cytokines and Growth factors signal through tyrosine phosphorylation of a family of related transcription factors. Immunity. 1(6). 457–468. 77 indexed citations
9.
Carter‐Su, Christin, Lawrence S. Argetsinger, George S. Campbell, et al.. (1994). The Identification of JAK2 Tyrosine Kinase as a Signaling Molecule for Growth Hormone. Experimental Biology and Medicine. 206(3). 210–215. 20 indexed citations
10.
List, Alan F., Paul A. Greenberg, S Woodward, et al.. (1994). Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood. 84(4). 1243–1248. 122 indexed citations
11.
List, Alan F., Paul A. Greenberg, S Woodward, et al.. (1994). Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood. 84(4). 1243–1248. 9 indexed citations
12.
Brenner, Malcolm K., Wayne L. Furman, Victor M. Santana, et al.. (1992). Phase I Study of Cytokine-Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapse/Refractory Neuroblastoma. Human Gene Therapy. 3(6). 665–676. 27 indexed citations
15.
Brenner, Malcolm K., Joseph Mirro, Craig A. Hurwitz, et al.. (1991). Autologous Bone Marrow Transplant for Children with AML in First Complete Remission: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of Relapse. Human Gene Therapy. 2(2). 137–159. 25 indexed citations
16.
Naparstek, Elizabeth, D Metcalf, RK Shadduck, et al.. (1986). Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow stromal cell lines. Blood. 67(5). 1395–1403. 42 indexed citations
17.
Rapp, Ulf R., Tom I. Bonner, Karin Moelling, et al.. (1985). Genes and Gene Products Involved in Growth Regulation of Tumor Cells. Recent results in cancer research. 99. 221–236. 18 indexed citations
18.
Prystowsky, M B, D I Beller, Leonard M. Eisenberg, et al.. (1982). Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes.. The Journal of Immunology. 129(6). 2337–2344. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026